Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases

Keyword: Plasma Levels

Publisher: GlobeNewswire

Published: Jun 19, 2026

First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014s safety and tolerabilityKIT2014 is being developed as an inhalation therapy for respiratory diseases incl… [+6669 chars]

Read Full Story ↗